Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

More questions than answers

From Mr C. I. Toothill, MRPharmS

The article by Claire Church and Jane Smith (PJ, 21 January, p75 PDF (60K)) provided a fascinating and informative review of the stability of medicines and their suitability for inclusion in compliance aids. However, I think this article will make a grey area even less clear for pharmacists.

There can be no doubt that compliance aids are popular with the patients who use them. However, some of the most commonly used medicines (eg, senna) are classed with the stability code of 1 (the most unstable code) and are therefore unsuitable for inclusion in a compliance aid. Indeed any medicine in a stability code of 1 to 3 leaves the pharmacist on unsafe ground if they place it into such a device.

Is the preferred option to dispense these drugs into other approved containers and risk complicating the medicine regimen of a patient who already has compliance problems? Or is it best to carry on and leave oneself supplying medicines outside the terms of their product licence? As the well-known song goes: “There are more questions than answers.”

Chris Toothill
Cleckheaton, West Yorkshire

Citation: The Pharmaceutical Journal URI: 10020784

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Similar topics

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.